search
Back to results

NIR and Skin Cancer Margins

Primary Purpose

Non-melanoma Skin Cancer

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Near-infrared heating
Sponsored by
Western University, Canada
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Non-melanoma Skin Cancer

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

The patient population includes individuals with a nonmelanotic cervicofacial cutaneous malignancy referred to a tertiary care skin cancer clinic for definitive treatment. Patients must have:

  • Histologically confirmed nonmelanotic cutaneous malignancies, either basal cell or squamous cell carcinoma
  • No prior treatment with investigational agents
  • Ability to tolerate intended treatment Patient's age is greater than or equal to 18 years

Exclusion Criteria:

  • Prior radiation therapy or photodynamic therapy to the area with the NMSC lesion
  • Patients with a history of cutaneous photosensitization
  • Unable to consent

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    No Intervention

    Experimental

    Arm Label

    Standard of care (control)

    NIR heating

    Arm Description

    This will be the standard of care group. The excision of the non-melanoma skin cancer will be based on standard visual inspection with 4-6mm margins.

    This will be the NIR heating group, where the excision of the non-melanoma skin cancer will be based on the lesion margins based on the application of near-infrared radiation (with 4-6mm margins).

    Outcomes

    Primary Outcome Measures

    Margin status
    Difference in margin status between the control and the near-infrared heating group.

    Secondary Outcome Measures

    Skin vascularity changes
    Visual changes in the vasculature of normal skin and NMSC skin following application or NIR light.

    Full Information

    First Posted
    September 23, 2019
    Last Updated
    September 23, 2019
    Sponsor
    Western University, Canada
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04103658
    Brief Title
    NIR and Skin Cancer Margins
    Official Title
    Near-infrared Heating of Skin to Delineate Non-melanoma Skin Cancer Lesions: a Pilot Study.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2019
    Overall Recruitment Status
    Unknown status
    Study Start Date
    September 30, 2019 (Anticipated)
    Primary Completion Date
    December 30, 2019 (Anticipated)
    Study Completion Date
    December 30, 2019 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Western University, Canada

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    We aim to determine whether the application of near-infrared radiation via standard heat lamp to non-melanoma skin lesions (such as basal cell carcinomas) before surgical excision is able to better delineate the lesion and surgical margins. If found to do so, pre-heating of skin lesions could lead to more specimens with negative margins. Patients presenting to the tertiary care centre skin cancer clinic for excision of skin cancer will be approached and offered to participate in the study.
    Detailed Description
    Non-melanoma skin cancer (NMSC) is the most common cancer diagnosis in Canada, and its incidence is still increasing. Visual examination followed by biopsies of suspicious lesions are the gold standard for skin cancer diagnosis. The mainstays of treatment include photodynamic therapy, radiation therapy, and surgical excision. The margins of NMSC lesions are typically determined via visual inspection, and excised based on delineating normal from abnormal tissue. According to the National Comprehensive Cancer Network, low-risk basal cell cancers should be excised with a 4mm margin; squamous cell skin cancers and high-risk basal cell cancers should be excised with 4-6mm margins, as per the National Comprehensive Cancer Network. These lesions frequently occur on cosmetically sensitive areas of the head and neck, therefore accurate margins and excision can help to preserve the overall appearance. Accurate lesion delineation with proper margins can also reduce the need for further treatment if the margins are positive. In approximately 2-3% of cases at our centre, the margins are positive. Near-infrared radiation (NIR) represents the light spectrum from 0.7 to 1.5 micrometers. At the shorter wavelengths, it merges with the red spectrum of visible light. These forms of light have the ability to heat the skin up to a 5 mm depth. Previous studies have examined the relationship between skin blood flow and temperature when heating skin, where dermal temperature can reach a certain peak in a defined time. Other studies have investigated the application of NIR when combined with photo immunotherapy, as a means of treating other cancers. More elaborate multispectral analysis devices have been studied for their effectiveness in diagnosing cutaneous malignancies. NIR application is well tolerated, in past studies.The objective of this study is to determine if the vasculature of normal skin and NMSC skin appears differently following heating with NIR light, and if this difference corresponds to better margin delineation. The excisions and reconstructions are all within the standard of care. The only added testing will be application of near-infrared heat via a heating lamp to the lesional skin, for a total of ten minutes. Each patient will have their skin cancer lesion photographed, and traced onto acetate film. The NIR heating will then occur under a lamp for a total of ten minutes at a distance of 20cm. At the end of the ten minutes, the lesion and its borders will again be traced onto a separate acetate film. Using Excel for block randomization, patients will then be randomized to excision with the non-heated versus heated margins. The allocation will not be known until the moment of assignment. The excisions will then occur in the same fashion between the two groups, and all specimens will be submitted for pathology, as is standard of care. Data will be recorded for various patient and lesions factors that may potentially influence the outcome of NIR heating therapy. These include age and gender, lesion size and location, and history of skin disorders. The lesion size and final pathology, with quantitative margin distances, will be recorded. Statistical analysis will be performed to determine if there is an overall difference in qualitative (negative or positive) and quantitative margin status between those lesions excised under standard procedure vs. NIR heating.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Non-melanoma Skin Cancer

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Masking Description
    Patients will be randomly assigned to the group of excision without or with near-infrared heat. Both the patient and investigator will be aware of the group allocation prior to the definitive excision.
    Allocation
    Randomized
    Enrollment
    20 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Standard of care (control)
    Arm Type
    No Intervention
    Arm Description
    This will be the standard of care group. The excision of the non-melanoma skin cancer will be based on standard visual inspection with 4-6mm margins.
    Arm Title
    NIR heating
    Arm Type
    Experimental
    Arm Description
    This will be the NIR heating group, where the excision of the non-melanoma skin cancer will be based on the lesion margins based on the application of near-infrared radiation (with 4-6mm margins).
    Intervention Type
    Radiation
    Intervention Name(s)
    Near-infrared heating
    Intervention Description
    Same as the arm/group description. The NIR heating group will have the non-melanoma skin cancer lesion excised based on the lesion borders established from application of NIR heat at a distance of 20cm for 10 minutes.
    Primary Outcome Measure Information:
    Title
    Margin status
    Description
    Difference in margin status between the control and the near-infrared heating group.
    Time Frame
    3 months
    Secondary Outcome Measure Information:
    Title
    Skin vascularity changes
    Description
    Visual changes in the vasculature of normal skin and NMSC skin following application or NIR light.
    Time Frame
    3 months

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: The patient population includes individuals with a nonmelanotic cervicofacial cutaneous malignancy referred to a tertiary care skin cancer clinic for definitive treatment. Patients must have: Histologically confirmed nonmelanotic cutaneous malignancies, either basal cell or squamous cell carcinoma No prior treatment with investigational agents Ability to tolerate intended treatment Patient's age is greater than or equal to 18 years Exclusion Criteria: Prior radiation therapy or photodynamic therapy to the area with the NMSC lesion Patients with a history of cutaneous photosensitization Unable to consent
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Kiersten Pianosi, MD
    Phone
    519-685-8500
    Ext
    18074
    Email
    kpianosi@uwo.ca
    First Name & Middle Initial & Last Name or Official Title & Degree
    Corey Moore, MD
    Phone
    519-685-8500
    Ext
    66383
    Email
    corey.moore@sjhc.london.on.ca

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    NIR and Skin Cancer Margins

    We'll reach out to this number within 24 hrs